References
- Blumenthal M, Busse WR, Goldberg A, et al. (1998). The Complete German Commission E Monographs: therapeutic guide to herbal medicines. Austin: American Botanical Council
- Boudinot FD, Jusko WJ. (1984). Fluid shifts and other factors affecting plasma protein binding of prednisolone by equilibrium dialysis. J Pharm Sci 73:774–80
- Chiou WL. (1978). Critical evaluation of the potential error in pharmacokinetic studies of using the linear trapezoidal rule method for the calculation of the area under the plasma level–time curve. J Pharmacokinet Biopharm 6:539–46
- Cioaca C, Margineanu C, Cucu V. (1978). The saponins of Hedera helix with antibacterial activity. Pharmazie 33:609–10
- Davis B, Morris T. (1993). Physiological parameters in laboratory animals and humans. Pharm Res 10:1093–5
- Demirci B, Goppel M, Demirci F, et al. (2004). HPLC profiling and quantification of active principles in leaves of Hedera helix L. Pharmazie 59:770–4
- Gibaldi M, Perrier D, eds. (1982). Pharmacokinetics, 2nd ed. New York: Marcel–Dekker, Inc
- Hawksworth G, Drasar BS, Hill MJ. (1971). Intestinal bacteria and the hydrolysis of glycosidic bonds. J Med Microbiol 4:451–9
- Khdair A, Mohammad MK, Tawaha K, et al. (2010). A validated RP HPLC-PAD method for the determination of hederacoside C in Ivy-Thyme cough syrup. Int J Anal Chem 2010: pii: article id 478143
- Lee MG, Chiou WL. (1983). Evaluation of potential causes for the incomplete bioavailability of furosemide: gastric first-pass metabolism. J Pharmacokinet Biopharm 11:623–40
- Lee YS, Kim YW, Kim SG, et al. (2012). Effects of poloxamer 407-induced hyperlipidemia on the pharmacokinetics of carbamazepine and its 10,11-epoxide metabolite in rats: impact of decreased expression of both CYP3A1/2 and microsomal epoxide hydrolase. Eur Neuropsychopharmacol 22:431–40
- Øie S, Guentert TW. (1982). Comparison of equilibrium time in dialysis experiments using spiked plasma or spiked buffer. J Pharm Sci 71:127–8
- Scheline RR. (1973). Metabolism of foreign compounds by gastrointestinal microorganisms. Pharmacol Rev 25:451–523
- Shim HJ, Lee EJ, Kim SH, et al. (2000). Factors influencing the protein binding of a new phosphodiesterase V inhibitor, DA-8159, using an equilibrium dialysis technique. Biopharm Drug Dispos 21:285–91
- Trute A, Gross J, Mutschler E, et al. (1997). In vitro antispasmodic compounds of the dry extract obtained from Hedera helix. Planta Med 63:125–9
- Wichtl M, Bisset NG. (1994). Herbal drugs and phytopharmaceuticals. Stuttgart: Medpharm GmbH Scientific
- Yakovishin LA, Grishkovets VI. (2003). Triterpene glycosides of the medicinal preparation Hedelix®. Chem Nat Comp 39:508–9
- Yu K, Chen F, Li C. (2012). Absorption, disposition, and pharmacokinetics of saponins from Chinese medicinal herbs: what do we know and what do we need to know more? Curr Drug Metab 13:577–98
- Zhu H, Ding L, Shakya S, et al. (2011). Simultaneous determination of asperosaponin VI and its active metabolite hederagenin in rat plasma by liquid chromatography-tandem mass spectrometry with positive/negative ion-switching electrospray ionization and its application in pharmacokinetic study. J Chromatogr B Analyt Technol Biomed Life Sci 879:3407–14